Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Conflicted on These Consumer Cyclical Names: Hermes International (OtherHESAF) and Expedia (EXPE)

Tipranks - Thu Apr 16, 3:02AM CDT

Analysts have been eager to weigh in on the Consumer Cyclical sector with new ratings on Hermes International (HESAF) and Expedia (EXPE).

Claim 30% Off TipRanks

Hermes International (HESAF)

RBC Capital analyst Piral Dadhania maintained a Buy rating on Hermes International today and set a price target of EUR2100.00. The company’s shares closed last Tuesday at $2072.50, close to its 52-week low of $2015.16.

According to TipRanks.com, Dadhania has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -7.1% and a 34.3% success rate. Dadhania covers the NA sector, focusing on stocks such as The Swatch Group, PUMA SE NPV, and Ferrari. ;'>

Hermes International has an analyst consensus of Moderate Buy, with a price target consensus of $2650.42, a 25.9% upside from current levels. In a report issued on April 1, Deutsche Bank also maintained a Buy rating on the stock with a EUR2320.00 price target.

See the top stocks recommended by analysts >>

Expedia (EXPE)

In a report released yesterday, Ken Gawrelski from Wells Fargo maintained a Hold rating on Expedia, with a price target of $310.00. The company’s shares closed last Tuesday at $248.57.

According to TipRanks.com, Gawrelski is a 4-star analyst with an average return of 5.6% and a 52.1% success rate. Gawrelski covers the NA sector, focusing on stocks such as Reddit Inc Class A, Alphabet Class A, and Meta Platforms. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Expedia with a $275.81 average price target, a 12.8% upside from current levels. In a report issued on April 6, Truist Financial also maintained a Hold rating on the stock with a $246.00 price target.

Read More on HESAF:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.